Antiflammins: Endogenous nonapeptides with regulatory effect on inflammation
- 1 January 1997
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 28 (1) , 23-26
- https://doi.org/10.1016/s0306-3623(96)00151-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Time-course of phospholipase A2, eicosanoid release and cellular accumulation in rat immunological air pouch inflammationInternational Journal of Immunopharmacology, 1993
- Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: Possible mechanism of actionLife Sciences, 1991
- Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activitiesInflammation Research, 1991
- Prolactin enhances uteroglobin gene expression by uteri of immature rabbitsReproduction, 1991
- ‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2 ‐inhibitory and anti‐inflammatory activityFEBS Letters, 1990
- Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.The Journal of Experimental Medicine, 1990
- Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretionBiochemical and Biophysical Research Communications, 1989
- Refinement of the C2221 crystal form of oxidized uteroglobin at 1.34 Å resolutionJournal of Molecular Biology, 1987
- Uteroglobin inhibits phospholipase A2 activityLife Sciences, 1986
- Lysophosphatidylserine as histamine releaser in mice and ratsInflammation Research, 1984